(Q44401594)

2 December 2017

title

Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses (English)

1 reference

2 December 2017

Luis M Ruilope

5

0 references

author name string

Juliá Segura

1

1 reference

2 December 2017

Manuel Praga

2

1 reference

2 December 2017

Carlos Campo

3

1 reference

2 December 2017

José L Rodicio

4

1 reference

2 December 2017

publication date

1 March 2003

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

2 December 2017

published in

1 reference

2 December 2017

volume

4

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

43-47

1 reference

Chymase-dependent angiotensin II forming systems in humans

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Angiotensin receptors and their antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Understanding the nature of renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

The Rapidity of Drug Dose Escalation Influences Blood Pressure Response and Adverse Effects Burden in Patients With Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Dosing of antihypertensive medications in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2003.007

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2003.007

1 reference

2 December 2017

1 reference